$BEAM
Beam Therapeutics Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$24.00
▼-2.95%-$0.730
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateBeam Therapeutics Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is BEAM down today? It is at $24.00 (-2.95%), and our scanner flagged it 129 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment BEAM spikes, and full due diligence on BEAM — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $BEAM 129 times in the last 30 days. Create a free account to track $BEAM, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on BEAM from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for BEAM today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystBeam Therapeutics Inc.: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Oct 17, 2026 · todaySources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Cavanagh Bethany J Officer | Sold (automatic/other) | -187 | sold 0.4% | 51K | $5K at $24.41 | Oct 1, 26 |
Ciaramella Giuseppe Officer | Sold (automatic/other) | -123K 0.1% of company | sold 49% | 131K | n/a | Sep 24, 26 |
Simon Amy Officer | Sold (automatic/other) | -17K 0.02% of company | sold 16% | 86K | $429K at $25.74 | Jul 27, 26 |
Evans John M. Officer | Sold (automatic/other) | -25K 0.02% of company | sold 2.3% | 1.05M | $857K at $34.26 | Jun 30, 26 |
Evans John M. Officer | Other | 25K 0.02% of company | added 2.4% | 1.07M | $26K at $1.03 | Jun 30, 26 |
Simon Amy Officer | Sold (automatic/other) | -373 | sold 0.4% | 102K | $13K at $34.73 | Jun 30, 26 |
Evans John M. Officer | Sold (automatic/other) | -25K 0.02% of company | sold 2.3% | 1.05M | $878K at $35.13 | Jun 29, 26 |
Evans John M. Officer | Other | 25K 0.02% of company | added 2.4% | 1.07M | $17K at $0.670 | Jun 29, 26 |
Fmr Llc Beneficial Owner (10%) | Sold (automatic/other) | -251K 0.2% of company | sold 13% | 1.70M | $8.9M at $35.26 | Jun 26, 26 |
Fmr Llc Beneficial Owner (10%) | Sold (automatic/other) | -33K 0.03% of company | sold 2.9% | 1.11M | $1.2M at $35.12 | Jun 25, 26 |
Ciaramella Giuseppe Officer | Other | 36K 0.03% of company | added 16% | 254K | $24K at $0.670 | Jun 17, 26 |
Ciaramella Giuseppe Officer | Sold (automatic/other) | -12K 0.01% of company | sold 5.1% | 218K | $290K at $24.58 | Apr 1, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on BEAM from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for BEAM today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
BEAM last traded at $24.00, down 2.95% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Beam Therapeutics Inc. Common Stock (BEAM) is next expected to report earnings on Tuesday, November 3, 2026, about 17 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
Yes. BEAM currently has a dividend yield of about 3.83% ($0.90 per share per year). Dividend figures can change; this is not investment advice.
The BEAM Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged BEAM 129 times in the last 30 days.
BEAM (Beam Therapeutics Inc. Common Stock) trades on XNAS, with a market cap of about $2.42B in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge BEAM for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$BEAM discussion
Sign in to ask a question or join the discussion.